166 results
Page 3 of 9
6-K
EX-99
rydtzocnlqrdfdhl
12 Sep 22
BioLineRx Announces Submission of New Drug Application
8:16am
6-K
EX-99
5cjw5
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
yc30x84ej5ko1d
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
tz8ijk4j234nt4n
28 Jun 22
BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in
7:14am
6-K
EX-99
arht2
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am
6-K
EX-99
94d0if9cnt s0
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
6-K
EX-99
5h1 xab7wdh
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
6-K
EX-99
cxy2r vvtmit
16 Mar 22
BioLineRx Reports Fourth Quarter 2021 Financial Results
7:11am
6-K
EX-99
oa64w8in
3 Mar 22
BioLineRx Announces Additional Positive Results from
7:10am
6-K
EX-99
ybb85quv
24 Jan 22
BioLineRx Announces Completion of Enrollment of Phase 1/2a
7:11am
6-K
EX-99
vk3dieuz1fn5109y8d3e
18 Jan 22
BioLineRx Announces Successful Completion of Pre-NDA
7:11am
6-K
EX-99
7vjfpr zbnxzjzd087
17 Dec 21
BioLineRx Provides Highlights from Oral Presentation
7:10am
6-K
EX-99
0j3 ftdzg5gwyo629o
15 Dec 21
BioLineRx Announces Formation of Immuno-Oncology
7:25am
6-K
EX-99
nijwqjqeooj
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
m1h7y1f
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-1
sfocho
4 Nov 21
BioLineRx Announces an Oral Presentation and Three
10:15am
6-K
EX-99
vu9 na75hqc0q4f651dr
13 Oct 21
BioLineRx Announces Positive Results from
8:37am
424B5
nwq zo7rvuqa8mlvei
3 Sep 21
Prospectus supplement for primary offering
4:29pm